Muromegalovirus
- Pathogenesis and ImmunityHeterologous Immunity and Persistent Murine Cytomegalovirus Infection
- Genome Replication and Regulation of Viral Gene ExpressionDominant Negative Mutants of the Murine Cytomegalovirus M53 Gene Block Nuclear Egress and Inhibit Capsid Maturation
- Genome Replication and Regulation of Viral Gene ExpressionMutations in the M112/M113-Coding Region Facilitate Murine Cytomegalovirus Replication in Human Cells
- Vaccines and Antiviral AgentsA Spread-Deficient Cytomegalovirus for Assessment of First-Target Cells in Vaccination
- Genome Replication and Regulation of Viral Gene ExpressionRapamycin-Resistant mTORC1 Kinase Activity Is Required for Herpesvirus Replication
- Genome Replication and Regulation of Viral Gene ExpressionBiphasic Recruitment of Transcriptional Repressors to the Murine Cytomegalovirus Major Immediate-Early Promoter during the Course of Infection In Vivo
- Genome Replication and Regulation of Viral Gene ExpressionStability of Murine Cytomegalovirus Genome after In Vitro and In Vivo Passage
- Genome Replication and Regulation of Viral Gene ExpressionMurine Cytomegalovirus US22 Protein pM140 Protects Its Binding Partner, pM141, from Proteasome-Dependent but Ubiquitin-Independent Degradation